{"name":"Woman's","slug":"woman-s","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Saxagliptin-Metformin XR","genericName":"Saxagliptin-Metformin XR","slug":"saxagliptin-metformin-xr","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"DAPA/MET XR","genericName":"DAPA/MET XR","slug":"dapa-met-xr","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"EQW plus DAPA","genericName":"EQW plus DAPA","slug":"eqw-plus-dapa","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"Exenatide once weekly (EQW )","genericName":"Exenatide once weekly (EQW )","slug":"exenatide-once-weekly-eqw","indication":"Type 2 diabetes mellitus","status":"phase_3"},{"name":"Metformin XR plus liraglutide","genericName":"Metformin XR plus liraglutide","slug":"metformin-xr-plus-liraglutide","indication":"Type 2 diabetes mellitus","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Dexamethasone Mouthwash","genericName":"Dexamethasone Mouthwash","slug":"dexamethasone-mouthwash","indication":"Oral inflammation and ulceration","status":"marketed"},{"name":"anti oxidant omega 3","genericName":"anti oxidant omega 3","slug":"anti-oxidant-omega-3","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Saxagliptin-Metformin XR","genericName":"Saxagliptin-Metformin XR","slug":"saxagliptin-metformin-xr","phase":"phase_3","mechanism":"Saxagliptin inhibits DPP-4 to increase incretin levels and lower blood glucose, while metformin XR reduces hepatic glucose production and improves insulin sensitivity.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"DAPA/MET XR","genericName":"DAPA/MET XR","slug":"dapa-met-xr","phase":"phase_3","mechanism":"DAPA/MET XR is a fixed-dose combination of dapagliflozin (SGLT2 inhibitor) and metformin extended-release that lowers blood glucose by increasing urinary glucose excretion and reducing hepatic glucose production.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Dexamethasone Mouthwash","genericName":"Dexamethasone Mouthwash","slug":"dexamethasone-mouthwash","phase":"marketed","mechanism":"Dexamethasone is a corticosteroid that suppresses local inflammation and immune responses in the oral cavity when applied topically as a mouthwash.","indications":["Oral inflammation and ulceration","Aphthous ulcers","Oral lichen planus","Post-operative oral inflammation"],"catalyst":""},{"name":"EQW plus DAPA","genericName":"EQW plus DAPA","slug":"eqw-plus-dapa","phase":"phase_3","mechanism":"EQW (semaglutide) is a GLP-1 receptor agonist combined with DAPA (dapagliflozin), an SGLT2 inhibitor, to provide dual glucose-lowering effects through incretin mimicry and urinary glucose excretion.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Exenatide once weekly (EQW )","genericName":"Exenatide once weekly (EQW )","slug":"exenatide-once-weekly-eqw","phase":"phase_3","mechanism":"Exenatide is a GLP-1 receptor agonist that stimulates insulin secretion in response to elevated blood glucose and slows gastric emptying to reduce postprandial glucose levels.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"Metformin XR plus liraglutide","genericName":"Metformin XR plus liraglutide","slug":"metformin-xr-plus-liraglutide","phase":"phase_3","mechanism":"Metformin XR reduces hepatic glucose production and improves insulin sensitivity, while liraglutide stimulates insulin secretion and reduces glucagon in a glucose-dependent manner via GLP-1 receptor activation.","indications":["Type 2 diabetes mellitus"],"catalyst":""},{"name":"anti oxidant omega 3","genericName":"anti oxidant omega 3","slug":"anti-oxidant-omega-3","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxPQjg4LVZzb1Bqd0ZkNTBkaWJaZ2JsRUpBeE9vckJDMzNXdE5sWFJETXhESVhNbERmX1doQmZ1ZkNPZmVUc09kYy1jb2prZEhvemlUWjQ1QnhZbmNjZ0hCMDZENUNBXzdrSHM3dW01NlhaTXNLdFJ2dDU4bERLYlFGMThZWXhNMVRpNkNGNDd3?oc=5","date":"2026-03-24","type":"pipeline","source":"Pharma Voice","summary":"Women in biotech hit a leadership plateau as board barriers persist - Pharma Voice","headline":"Women in biotech hit a leadership plateau as board barriers persist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQUGs1U0txWDR5V0MzQWYzNnlOUGVKNXVpVmVqNWVmeklSNzl4V1pUTXNBLU5mZDRhNGtRR2xjcG9iODdYdHNTVkpoMkFFVlZ1RjFvU054b2Y4QjNLTTc5dnIzOGRtNVVkM3pNcjdzYkJ5OE9vMUt4enIwUkZtU3V3eEkyc0RSUdIBiwFBVV95cUxOUGRTSTlhUG53ZF9JZ2RfcWpORTNhVHlhY1hlZ2VOcEpjX0E3a0pQSWIxNHREVVUzSFVUVUtKY2JpSGlMSHU0bWJlbnNBZm9JWlFHUWNEQW9SdUhsZlBuYkNNdHRpT3dubjI2ZjlmbFV4U0ltNlpJVlMwc3ZudmRkU0lKZUc4eVM4eVlj?oc=5","date":"2026-03-08","type":"pipeline","source":"Express Pharma","summary":"To all women in pharma, current and future leaders - Express Pharma","headline":"To all women in pharma, current and future leaders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxOOUxOdXJjZ0FiWEUxWDFuRjRYUW9idjNYRHZ3MkNvWTgtSVhsWmdFQWRmdkw5SVc1ZUk2OXM3MG5kREp1eXJUWFd3bmprSkR1NlZucF9BcVg4ZkQteXpXU2xIOGVJR19CWm14Z3JjZ3F6VDMzTjhmQ293RmoxMlVPUXJtWEpSR3lKdkE?oc=5","date":"2026-02-02","type":"pipeline","source":"PharmTech.com","summary":"Women in STEM: Inspiration from Innovators in Pharma - PharmTech.com","headline":"Women in STEM: Inspiration from Innovators in Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAJBVV95cUxQNklpMjRsRThMUVNSdU0ybDJXQTlxcDFlTmtOWUV1dUZUMDV2aS1MV2p3YlVPd2NuT19mYnpPMlRLY21QcmtwYi1GcEw1aXBmaTExeUdTQ0t1cG1nZDBCRkNMd1cxc1FXVlMyM01DeE1zR1ZaRkxLTUZXR2JHcHhvM1Vzb04zOGpJQkdCRnotalVHalNZWTZxME96RDFtdnBhMWJjcHk1eE9NU0xHYUJfUXVrekZHVFI0cXRUU1pFUE5yWU1YNUNhbHZPOGFqSzJkblRjSEtpQ0JGMi1fdEFSeXdXXzctZjlOQjJEandZeWY0ZzlhTjc4bVBGal9yLS1x?oc=5","date":"2025-12-09","type":"pipeline","source":"VnExpress International","summary":"From chemistry teacher to pharma tycoon: How Zhong Huijuan became Asia’s richest self-made woman billionaire - VnExpress International","headline":"From chemistry teacher to pharma tycoon: How Zhong Huijuan became Asia’s richest self-made woman billionaire","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQbjNoTXk0a1k0Mm0wZW9DME9PdEVRT042Y0ZfRHZBZjRQRmhSZlhyMFVhYnRWbjkwc2pIa1VEU2E0Q042dmR1UFM0UzdGQk5Ldm9BMFl3NFYxUF9aVnYtbVBPTy1VT05XU3l4OTJkQXFBeldSUmJsUkRoX1RKbjhJaXIxZHY1WG9RSEdSNTcxelMxd3EwWnlsUGM1MkRwQjhBMS0xY0ZNcEViT192aVUwLXlzYldQODdYUmM5Q1BrcFJUX1BDal9XX25lTmzSAdABQVVfeXFMTnEzX0RpV0hseU8wdV9uVWlkNXRxeG5LRTVpSW83b2FuX3Fyb2RDZmw4bkZ4UWQ3Y1ZLMk5RVDVZekV6aEZsYUl4Ynd0MVA3eThrZU5lcm1DRGVvcUZqWFFvRDUteWVweTlNS080QjZ3UkFjNXJoS1d1aVBsQUFYVFNORFY1LVRGUkRBU2tDSWxHU3NmSDNtMTVCNGRaTTRaenFxdWtpRGZhdGdibmJILWtGM0hoOG1UcjBnX2NFSFpuNWRNTmQ2QlJNaEdyaWVUag?oc=5","date":"2025-12-01","type":"pipeline","source":"Tribune India","summary":"Mumbai woman held at gunpoint, stripped; police register case against senior pharma officials - Tribune India","headline":"Mumbai woman held at gunpoint, stripped; police register case against senior pharma officials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxQQTVpZldKeEhDWGp0MGlid2V0aVRUMlVtOGp2VklqUVVaNnlaaDkzMVFSbnVYM1lURmJRb3ZOMm9jVml3UmZwdFBJaWVZT01KLURWQURvN19JNllhREVkWF9IZzRyQjFfWW9rQk12aXEyb2t2TWNkRm5Rbmg5bDEyU0hXR2I3UGZ6TjNzb1FzeTgtZmhzZlpLNE80WE9hZ2xtX2QyOGZDUlg2d0ZZZ3RXb1FZSTliQ1RmQnVUOXR2cGVhRUlETW5Gb3VCeHhzbks0YjhhLUhmU2MxNEN3U09ucXZRUV9KYWxxRWxpRUpkeGJvUzJTRzZyd1pn0gH_AUFVX3lxTE5vSzdVSkNoUUdvRGdMZ0kxLUNuTDZDeDNOamRzQll6cDA4VTJfLURrZWdZdTB3bjVtcGpQeGdfT05BZUVlS3Z2TkQxZjcyM2ctenJqdlpZN2ZHWm9lOU9mN3NMdTNTZVBldDkzMHFHZDJSQVZ2ZXRYaHo4OWlDWl8zc1UxeHc1bGwtVkVyN3RiVTNqd3RFQzlQRTRZdXlNU2dyQUJnQlpEMG1JR0xZR1c4bFZaUG92dzVzMDhhZW1POXUyMVRtUVlGZjU3ZF9vMm1yZnEzckRLaThicUJrNFEzV3lhYnZBUUxvS181R3FTQlFCUUI0YXN1YkJ4Q0RwSQ?oc=5","date":"2025-12-01","type":"pipeline","source":"Hindustan Times","summary":"Mumbai woman allegedly forced to strip at gunpoint by pharma firm officials; police launch probe | Mumbai news - Hindustan Times","headline":"Mumbai woman allegedly forced to strip at gunpoint by pharma firm officials; police launch probe | Mumbai news","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiekFVX3lxTE83VldBbWlBY0lkZU13QlkxVjZEQnVDUEl4aGJscWpwWHVnU05GVlRhZnVSazBfYjBYTl9WYVZwQncwSXJEMHVkSGgtZDRnTkZrSmtxRUZxMHVBT0FLa2lFUmpQbGlnLVpzaURSS3g2dU1uV3JKYzhZWXFn?oc=5","date":"2025-11-17","type":"pipeline","source":"Fierce Pharma","summary":"2025's Fiercest Women in Life Sciences - Fierce Pharma","headline":"2025's Fiercest Women in Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQRE0yVXFnM0J6MWdsSGlMZGdNZHNZSDVjVGRoZkxHQ2ZYQ19Yc2FfcFZDQThic3N0VWNxemNvN1prVDRka3dlMVliQmFJRkdFNmZLWVNjaVRYRkZXTXROMXlNTml4OWJVSzR3WGRXUE5wVG9aZmdyZm4tbUp0ajAtdTVrbGwtdlVJSDJ2bEhuMEFEQUtsaDVRU0JiVEVFVGs?oc=5","date":"2025-10-03","type":"pipeline","source":"Pharma Voice","summary":"With Emma Walmsley exiting GSK, who will be pharma’s top women CEOs? - Pharma Voice","headline":"With Emma Walmsley exiting GSK, who will be pharma’s top women CEOs?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNOExtbkFMTmpMemZ3MXRBX09XUVU1bURHNFZoanRXa1k1aHJ0eFRLSGx2RE9STzdBNFkzcngwRENFWkYyVEFsTE44OTNkT0ZiZ2xjS1JOSFRnckNFcXJsdm9mSEs3ZDUyNC1BRmdnRnc2YlpNelVEa2I4M0gwUm5kNWUzUGlzLVhRVmREOXlXUnEtTjQwaWNKYmQ3dFloX3FXNGdB?oc=5","date":"2025-09-29","type":"pipeline","source":"BioSpace","summary":"GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years - BioSpace","headline":"GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQckZtXzhSVm56RlhvVkkxeldLVTMyZjZ1ZGdHX1RrVk5rSWJORk1VbkxVcktza1RCMEJ5djBPMi1vcGlFX1FQTURVVmkxOVdURW5aem5sdVBELWgzRDZrWFhTZEJEN3RqanJ5ZTRQbkc1TXYzVlZ3Ym9HWjF3QXdVTXNJd0ZPTlNoTHc?oc=5","date":"2025-09-29","type":"regulatory","source":"BioPharma Dive","summary":"Emma Walmsley, big pharma’s first female CEO, to depart GSK - BioPharma Dive","headline":"Emma Walmsley, big pharma’s first female CEO, to depart GSK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQdVlLdmtrNlFKenlTaUpjVVB4cVZoN3dTcUVKXzR1aUVvaHZCTWt0dHM3eEJKcXBGNFVuUDlZSnZacFdSc0ZBSzNjaGF1YWREaVdzSzBWU1VkUkJ3UU1Ra0ItVnM5bHF4cVJvaFgxVEV2aU00S2dhNTNEVnZWanhSTVBqa0k4QzRGZ2h3QnU1U3BnRjRhR0NSN1E0eHY?oc=5","date":"2025-09-29","type":"pipeline","source":"BioSpace","summary":"GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling - BioSpace","headline":"GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxQRTBPYmxSRlhERTFkdGJCb1pfWjMxTHdkeHR1Y0FlWmw2MmxJallWczUzWUdhbFFFb19xaHJlX0lfMFEwMUYyMEx4V3NVTW9jTGZocHZOa2UtdWkxQUN1U2ttNkZodnQ4a2NtU092dm5zM0V6amVPRkF0VC1nQ2JnOXprcFJuNHpDR2hmZzN6OFBhdw?oc=5","date":"2025-06-01","type":"pipeline","source":"nypost.com","summary":"How one woman took on ‘Big Pharma’ and (mostly) won - nypost.com","headline":"How one woman took on ‘Big Pharma’ and (mostly) won","sentiment":"neutral"}],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":5,"marketed":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}